A previous study from our center showed that response-guided treatment with vasoconstrictors, albumin, and furosemide to maintain MAP >82 mmHg had better ascites control and improvement in AKI in acute on chronic liver failure patients [11]. The gene discussed is ALB; the disease is acute kidney injury.